{"disease":{"id":"dysentery-bacillary","name":"dysentery bacillary"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04865497","title":"Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1050,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03561181","title":"Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03527173","title":"A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03089879","title":"A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}